Registered entities
Ovid Therapeutics Inc.,
Reg. No. 46-5270895United States
Ovid Therapeutics Inc.
Reg. No. 1636651United States
Innovation
66 patent families (25 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace steady. Cited 6,321 times.
| Year | Filings |
|---|---|
| 2015 | 3 |
| 2016 | 4 |
| 2017 | 13 |
| 2018 | 16 |
| 2019 | 28 |
| 2020 | 29 |
| 2021 | 27 |
| 2022 | 14 |
| 2023 | 13 |
| 2024 | 18 |
| 2025 | 29 |
| 2026 | 7 |
Social engagement
Social engagement: 19.9K social following, 10 posts in the last 12 months — around the industry typical range.
Investor mix
8 investors on record; lead investors include Fidelity Investments.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 2 | 25% |
| Bank & private debt | 1 | 13% |
| Other / undisclosed | 5 | 63% |
Hiring activity
Hires occasionally
1 role tracked across 1 of the last 12 months
3 Feb 2026 · Clinical Operations (AD, Director, Sr Director) · Philadelphia
Based on job postings tracked across public sources.
Recent activity
3 Jun 2026
Leadership hire
Board of Directors
18 May 2026
Event
American Psychiatric Association annual meeting
14 Apr 2026
Event
KCC2 R&D Deep Dive Event